在膀癌中患者衍生器官:机遇和挑战
Martina Radić1, Martin Egger2, Marianna Kruithof-de Julio3
1Department for BioMedical Research, Urology Research Laboratory, University of Bern, Bern, Switzerland.
European urology focus
|September 5, 2024
概括
患者衍生器官 (PDO) 为膀癌 (BLCa) 研究和治疗提供了个性化的方法. 这些来自患者样本的3D模型显示出对预测治疗反应和推进BLCA精准医学的前景.
科学领域:
- 在瘤学瘤学.
- 生物技术是生物技术.
- 翻译医学是一种翻译医学.
背景情况:
- 膀癌 (BLCa) 由于高复发率和有限的治疗选择,存在重大挑战.
- 患者衍生器官 (PDO) 正在成为个性化癌症研究和药物查的强大工具.
- PDO为模拟BLCa生物学和预测个体患者对治疗的反应提供了一个有希望的平台.
研究的目的:
- 探索PDO在促进膀癌研究和治疗策略方面的潜力.
- 强调PDO在精密瘤学的转化临床应用.
- 评估从血液和尿液等最小侵入性样本中提取PDO的可行性.
主要方法:
- 由于BLC和PDO发布的数据稀缺,因此采用了叙事审查格式.
- 在癌症研究中对PDO的现有数据进行了全面的PubMed搜索.
- 进行了使用PDO在精密医学中的正在进行的临床试验的选.
主要成果:
- 来自患者的膀癌器官提供了一个个性化的模型,密切模仿患者的瘤.
- PDO可以帮助识别新的治疗选择,并预测患者对治疗的反应.
- 使用微侵袭性样本用于PDO衍生可以增强患者参与研究.
结论:
- BLCa PDO 具有显著的潜力,可以推进精准医学和个性化癌症治疗.
- 对于PDO生成和临床应用的标准化协议需要进一步开发.
- 需要确定PDO对患者结果的影响以及理想的临床整合策略.
相关概念视频
Cancer
51.7K
Cancers arise due to mutations in genes involved in the regulation of cell division, which leads to unrestricted cell proliferation. Modern science and medicine have made great strides in the understanding and treatment of cancer, including eradicating cancer in some patients. However, there is still no cure for cancer. This is largely due to the fact that cancer is a large group of many diseases.
51.7K
Adaptive Mechanisms in Cancer Cells
5.7K
Cancer cells accumulate genetic changes at an abnormally rapid rate due to the defects in the DNA repair mechanisms. From an evolutionary perspective, such genetic instability is advantageous for cancer development. Mutant cell lines accumulate a series of beneficial mutations that contribute to their progression into cancer.
Some of the advantages that cancer cells have on normal cells include - enhanced ability to divide without terminally differentiating, induce new blood vessel formation,...
Some of the advantages that cancer cells have on normal cells include - enhanced ability to divide without terminally differentiating, induce new blood vessel formation,...
5.7K
Stem Cell Therapy for Tissue Regeneration
3.8K
Stem cell therapy is a method used in regenerative medicine to repair and restore function to damaged tissues and organs. Stem cells have the potential to proliferate and differentiate into various tissue types, making them ideal candidates for tissue regeneration. For example, hematopoietic stem cell transplants are commonly used in blood cancer treatment to replenish damaged bone marrow and restore healthy blood cells.
Types of Stem Cells used in Stem Cell Therapy
The two main cell...
Types of Stem Cells used in Stem Cell Therapy
The two main cell...
3.8K
Bone Marrow Sampling and Transplants
3.0K
Bone marrow transplant is a potential cure for several diseases, including cancer and specific genetic disorders. Notably, this procedure is applicable for patients suffering from aplastic anemia, certain types of leukemia, severe combined immunodeficiency disease (SCID), Hodgkin's disease, non-Hodgkin's lymphoma, multiple myeloma, thalassemia, sickle-cell disease, and certain cancers.
The transplant begins with high doses of chemotherapy and radiation treatment, which aim to destroy...
The transplant begins with high doses of chemotherapy and radiation treatment, which aim to destroy...
3.0K
Tissue Transplantation
1.4K
Tissue transplantation is a significant medical procedure involving the transfer of cells, tissues, or organs from a donor to a recipient, with the primary aim of restoring lost functions. This procedure is crucial in treating a broad spectrum of diseases, including kidney diseases, liver failure, heart disease, and certain types of cancers.
The Biology of Tissue Transplantation
The biology of tissue transplantation hinges on the Major Histocompatibility Complex (MHC) molecules. These molecules...
The Biology of Tissue Transplantation
The biology of tissue transplantation hinges on the Major Histocompatibility Complex (MHC) molecules. These molecules...
1.4K
Kidney Transplant I: Introduction
827
A kidney transplant is a surgical approach that involves replacing a non-functioning kidney with a healthy one from a donor. This procedure is often a treatment option for end-stage renal disease (ESRD) patients. The method requires careful recipient selection, including evaluating various medical and psychosocial factors. These criteria vary between transplant centers but generally include assessments of the patient's overall health, adherence to medical recommendations, and lifestyle...
827


